You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR STIRIPENTOL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Stiripentol

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01533506 ↗	Stiripentol in Dravet Syndrome	No longer available	Mayo Clinic		2012-02-01	The patient has failed all other available agents and has intractable epilepsy due to Dravet Syndrome. Stiripentol is highly efficacious in Dravet Syndrome. The overall goals of therapy with Stiripentol are primarily to significantly reduce the frequency and severity of seizures.
NCT01835314 ↗	Compassionate Use of Stiripentol in Dravet Syndrome	No longer available	University of Colorado, Denver		1969-12-31	Compassionate use of Stiripentol in Dravet Syndrome. This is a treatment protocol, not a research study, therefore children will only be monitored on a clinical basis for seizure improvement predominantly by parent and caregiver report.
NCT01983722 ↗	Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome	Approved for marketing	Children's Hospital Medical Center, Cincinnati		1969-12-31	Expanded access to Stiripentol for patients with Dravet Syndrome.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Stiripentol

Condition Name

Chart
Table

Condition Name for Stiripentol
Intervention	Trials
Dravet Syndrome	6
Epilepsy	3
Epileptic Encephalopathies Associated With SCN1A Mutations	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Stiripentol
Intervention	Trials
Syndrome	6
Epilepsies, Myoclonic	6
Epilepsy	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Stiripentol

Trials by Country

Map
Table

Trials by Country for Stiripentol
Location	Trials
United States	11
France	4
Netherlands	3
Spain	3
Canada	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Stiripentol
Location	Trials
Ohio	2
Colorado	2
Minnesota	2
Pennsylvania	1
Michigan	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Stiripentol

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Stiripentol
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	2
Phase 2	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Stiripentol
Clinical Trial Phase	Trials
Completed	5
No longer available	3
Not yet recruiting	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Stiripentol

Sponsor Name

Chart
Table

Sponsor Name for Stiripentol
Sponsor	Trials
Biocodex	4
GW Research Ltd	2
Cambridge University Hospitals NHS Foundation Trust	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Stiripentol
Sponsor	Trials
Other	23
Industry	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.